|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
Patricia Hurter
|
|
gptkbp:focus
|
oral drug delivery
long-acting oral therapies
|
|
gptkbp:foundedYear
|
2015
|
|
gptkbp:founder
|
gptkb:Robert_Langer
gptkb:Amy_Schulman
Giovanni Traverso
|
|
gptkbp:headquartersLocation
|
gptkb:Watertown,_Massachusetts,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lyndra Therapeutics
|
|
gptkbp:industry
|
gptkb:biotechnology
pharmaceuticals
|
|
gptkbp:mission
|
improve medication adherence through long-acting oral therapies
|
|
gptkbp:notableCollaboration
|
gptkb:National_Institutes_of_Health
gptkb:Bill_&_Melinda_Gates_Foundation
gptkb:Gilead_Sciences
|
|
gptkbp:notableInvention
|
long-acting oral drug delivery system
|
|
gptkbp:notableInvestment
|
gptkb:Polaris_Partners
gptkb:Bill_&_Melinda_Gates_Foundation
gptkb:Gilead_Sciences
gptkb:Invus_Group
gptkb:Horizon_Ventures
Orient Life
Quark Venture
|
|
gptkbp:notableProduct
|
long-acting oral capsule
|
|
gptkbp:website
|
https://lyndra.com/
|
|
gptkbp:bfsParent
|
gptkb:Sol_Barer
gptkb:Robert_Samuel_Langer_Jr.
|
|
gptkbp:bfsLayer
|
7
|